The latest international news, analysis and features on the HIV epidemic from Avert. Share your views and expertise with your peers in the comments box below the articles.
Phase III trials of the intravenous drug ibalizumab have been found to significantly reduce viral load in people living with HIV who do not respond to existing treatment.
Despite a willingness of men to undergo voluntary medical male circumcision (VMMC) for HIV prevention benefits in sub-Saharan Africa, uptake is low with just 56% of the 20.8 million circumcisions by 2016 target met.
Women in Nigeria face cycles of stigma and poverty that severley limit their access to HIV serivces, including the prevention of mother-to-child transmission services.
Progress in halting TB – the world’s leading infectious disease killer – is plagued by a lack of political will and inequalities in healthcare access
Expanding access to treatment for people living with HIV is shown to decrease tuberculosis (TB) incidence – but it is not the silver bullet.
Study in South Africa and Burkina Faso shows that simple HPV screening could help save lives in places with limited health infrastructure.
Kenya becomes first country in the world to introduce child-friendly tuberculosis (TB) medicine. It is hoped that the roll-out of this medication will drastically reduce the number of child TB deaths in the country.